Publication for NCL and PTMA
| Species | Symbol | Function* | Entrez Gene ID* | Other ID | Gene coexpression |
CoexViewer |
|---|---|---|---|---|---|---|
| hsa | NCL | nucleolin | 4691 | [link] | ||
| hsa | PTMA | prothymosin alpha | 5757 |
| Pubmed ID | Priority | Text |
|---|---|---|
| 14519204 | 0.98 | PTMA, ODC1, LDHA, NCL and NPM1 are highest on the list for the number of references. |
| 23663694 | 0.96 | nucleolin and prothymosin alpha (PTMA) have been compared between PTC patients and healthy controls but no comparison was made with patients with benign nodules. |
| 32219217 | 0.94 | NCL) with PTMA; a transcription regulator involved in leukaemogenesis (PBX3) and an mRNA export mediator (GLE1); cell cycle progression protein (ANP32B) and the SET proto-oncogene. |
| 18851746 | 0.58 | NCL, NPM1, PTMA, and TP53, were expressed at higher levels in stage 4s-NA tumors (Table 1). |
The preparation time of this page was 0.0 [sec].
